# The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

> **NCT07468708** · EARLY_PHASE1 · RECRUITING · sponsor: **FindCure Biosciences (ZhongShan) Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Healthy Adult
- Prostate Cancer

## Interventions

- **DRUG:** ⁶⁸Ga-FC516
- **DRUG:** ⁶⁸Ga-FC516 and ⁶⁸Ga-labeled prostate cancer-targeting tracer

## Key facts

- **NCT ID:** NCT07468708
- **Lead sponsor:** FindCure Biosciences (ZhongShan) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-09
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07468708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07468708, "The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07468708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*